32 related articles for article (PubMed ID: 10397706)
1. Role of chimeric murine leukemia virus env beta-turn polyproline spacers in receptor cooperation.
Valsesia-Wittmann S
J Virol; 2001 Sep; 75(18):8478-86. PubMed ID: 11507193
[TBL] [Abstract][Full Text] [Related]
2. Nuclear import of moloney murine leukemia virus DNA mediated by adenovirus preterminal protein is not sufficient for efficient retroviral transduction in nondividing cells.
Lieber A; Kay MA; Li ZY
J Virol; 2000 Jan; 74(2):721-34. PubMed ID: 10623734
[TBL] [Abstract][Full Text] [Related]
3. Efficient infection mediated by viral receptors incorporated into retroviral particles.
Balliet JW; Bates P
J Virol; 1998 Jan; 72(1):671-6. PubMed ID: 9420272
[TBL] [Abstract][Full Text] [Related]
4. Efficient transduction by an amphotropic retrovirus vector is dependent on high-level expression of the cell surface virus receptor.
Kurre P; Kiem HP; Morris J; Heyward S; Battini JL; Miller AD
J Virol; 1999 Jan; 73(1):495-500. PubMed ID: 9847355
[TBL] [Abstract][Full Text] [Related]
5. Specific targeting of human interleukin (IL)-13 receptor α2-positive cells with lentiviral vectors displaying IL-13.
Ou W; Marino MP; Suzuki A; Joshi B; Husain SR; Maisner A; Galanis E; Puri RK; Reiser J
Hum Gene Ther Methods; 2012 Apr; 23(2):137-47. PubMed ID: 22612657
[TBL] [Abstract][Full Text] [Related]
6. The host range of gammaretroviruses and gammaretroviral vectors includes post-mitotic neural cells.
Liu XH; Xu W; Russ J; Eiden LE; Eiden MV
PLoS One; 2011 Mar; 6(3):e18072. PubMed ID: 21464894
[TBL] [Abstract][Full Text] [Related]
7. Antibody-induced internalisation of retroviral envelope glycoproteins is a signal initiation event.
Panova V; Attig J; Young GR; Stoye JP; Kassiotis G
PLoS Pathog; 2020 May; 16(5):e1008605. PubMed ID: 32453763
[TBL] [Abstract][Full Text] [Related]
8. Towards Physiologically and Tightly Regulated Vectored Antibody Therapies.
Page A; Fusil F; Cosset FL
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32295072
[TBL] [Abstract][Full Text] [Related]
9. Current advances in retroviral gene therapy.
Yi Y; Noh MJ; Lee KH
Curr Gene Ther; 2011 Jun; 11(3):218-28. PubMed ID: 21453283
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral vectors for immune cells targeting.
Froelich S; Tai A; Wang P
Immunopharmacol Immunotoxicol; 2010 Jun; 32(2):208-18. PubMed ID: 20085508
[TBL] [Abstract][Full Text] [Related]
11. Viral vectors: from virology to transgene expression.
Bouard D; Alazard-Dany D; Cosset FL
Br J Pharmacol; 2009 May; 157(2):153-65. PubMed ID: 18776913
[TBL] [Abstract][Full Text] [Related]
12. Molecular engineering of viral gene delivery vehicles.
Schaffer DV; Koerber JT; Lim KI
Annu Rev Biomed Eng; 2008; 10():169-94. PubMed ID: 18647114
[TBL] [Abstract][Full Text] [Related]
13. General strategy for decoration of enveloped viruses with functionally active lipid-modified cytokines.
Kueng HJ; Leb VM; Haiderer D; Raposo G; Thery C; Derdak SV; Schmetterer KG; Neunkirchner A; Sillaber C; Seed B; Pickl WF
J Virol; 2007 Aug; 81(16):8666-76. PubMed ID: 17537846
[TBL] [Abstract][Full Text] [Related]
14. A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor.
Snitkovsky S; Niederman TM; Carter BS; Mulligan RC; Young JA
J Virol; 2000 Oct; 74(20):9540-5. PubMed ID: 11000224
[TBL] [Abstract][Full Text] [Related]
15. Efficient gene delivery to quiescent interleukin-2 (IL-2)-dependent cells by murine leukemia virus-derived vectors harboring IL-2 chimeric envelope glycoproteins.
Maurice M; Mazur S; Bullough FJ; Salvetti A; Collins MK; Russell SJ; Cosset FL
Blood; 1999 Jul; 94(2):401-10. PubMed ID: 10397706
[TBL] [Abstract][Full Text] [Related]
16. Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope.
Lam JS; Reeves ME; Cowherd R; Rosenberg SA; Hwu P
Hum Gene Ther; 1996 Aug; 7(12):1415-22. PubMed ID: 8844200
[TBL] [Abstract][Full Text] [Related]
17. Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU.
Valsesia-Wittmann S; Morling FJ; Nilson BH; Takeuchi Y; Russell SJ; Cosset FL
J Virol; 1996 Mar; 70(3):2059-64. PubMed ID: 8627737
[TBL] [Abstract][Full Text] [Related]
18. Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains.
Tailor CS; Kabat D
J Virol; 1997 Dec; 71(12):9383-91. PubMed ID: 9371598
[TBL] [Abstract][Full Text] [Related]
19. Generation of high-titer pseudotyped retroviral vectors with very broad host range.
Yee JK; Friedmann T; Burns JC
Methods Cell Biol; 1994; 43 Pt A():99-112. PubMed ID: 7823872
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
